QSAR and molecular docking study of a series of combretastatin analogues tubulin inhibitors

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 4689 LNBI, Issue , 2007, Pages 436-444

  Ji, Yubin ^a   Tian, Ran ^a   Lin, Wenhan ^b  

^a HARBIN UNIVERSITY OF COMMERCE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ALGORITHMS; MOLECULAR DYNAMICS; POLYMERIZATION; THREE DIMENSIONAL;

B RING TRANSFORMATION; COMBRETASTATIN COMPOUNDS; COMPARATIVE MOLECULAR FIELD ANALYSIS (COMFA); COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS(COMSIA); DIPOLE MAG; GENETIC FUNCTION ANALYSIS(GFA); HBOND DONOR; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP(QSAR); TUBULIN POLYMERIZATION;

ENZYME INHIBITION;

EID: 38049151128     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-540-74771-0_50     Document Type: Conference Paper

References (10)

1. Si, Q., Mu, H., Yan: GIndividualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics. Hepatogastroenterology 3, 334-341 (2007)
2. Vyas, J.M., Kim, Y.M., Van der Veen, A.G.: Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells. J. Immunol. 1, 7199-7210 (2007)
3. Roth, D.M., Moseley, G.W., Glover, D.: Microtubule-Facilitated Nuclear Import Pathway for Cancer Regulatory Proteins. Traffic 1, 673-686 (2007)
4. Usui, T: Actin- and microtubule-targeting bioprobes: their binding sites and inhibitory mechanisms. Biosci. Biotechnol. Biochem. 2, 300-308 (2007)
5. Rappl, C., Barbier, P.: Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin. Biochemistry 8, 9210-9218 (2006)
6. Gurjar, M.K., Wakharkar, R.D., Singh, A.T.: Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents. J. Med. Chem. 4, 1744-1753 (2007)
7. Sun, L., Vasilevich, N.I., Fuselier, J.A.: Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice. Anticancer Res. 1, 179-186 (2004)
8. Simoni, D., Romagnoli, R., Baruchello, R., Pisano, C.: Novel combretastatin analogues endowed with antitumor activity. J. Med. Chem. 1, 3143-5312 (2006)
9. Eikesdal, H.P., Bjerkvig, R., Raleigh, J.A.: Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia. Radiother. Oncol. 12, 313-320 (2001)
10. Griggs, J., Brindle, K.M., Metcalfe, J.C., Hill, S.A., Smith, G.A.: Potent anti-metastatic activity of combretastatin-A4. Int. J. Oncol. 10, 821-825 (2001)